Back to Authors

Dahlin, David C.

A5108345321 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 5

Multicystic Dysplasia of the Kidney: With Special Reference to The Contralateral Kidney

Journal of Urology | July 10, 2017 | Volume: 105 | Issue: 4 | Pages: 482-487

10.1016/s0022-5347(17)61553-2 | PMID 5556691

Benign Chondroblastoma of The Temporal Bone

Otolaryngology–Head and Neck Surgery | April 8, 2016 | Volume: 87 | Issue: 2 | Pages: 229-236

10.1177/019459987908700213 | PMID 503493

Benign chondroblastoma is a rare tumor in the temporal bone. It occurs preponderantly in middle‐aged men as a mass in the posterosuperior region of the ear canal and is accompanied by hearing loss. On pathologic examination, giant cells and focal regions of chondroid differentiation are noted. After the extent of the tumor has been determined, the treatment is surgical removal. Preoperative irradiation may be helpful. Long‐term follow‐up is essential.
Chondroblastoma of the Skull and Facial Bones

American Journal of Clinical Pathology | March 17, 2016 | Volume: 88 | Issue: 1 | Pages: 1-9

10.1093/ajcp/88.1.1 | PMID 3604981

Radium-226, Radium-228, Lead-210, and Fluorine in Persons With Osteogenic Sarcoma

Science | October 5, 2006 | Volume: 144 | Issue: 3626 | Pages: 1573-1575

10.1126/science.144.3626.1573 | PMID 14169342

Concentrations of the naturally occurring alpha-emitting radioelements, radium-226, radium-228, and lead-210, and of stable lead and fluorine were determined in bone specimens from 32 individuals having a verified osteogenic sarcoma. Comparison of these results with those for the average person showed no significant differences in either the absorbed dose (rad) from the accumulated radioisotopes or in the concentrations of the elements studied.
Primary reticulum‐cell sarcoma of bone

Cancer | June 24, 2006 | Volume: 5 | Issue: 6 | Pages: 1182-1192

10.1002/1097-0142(195211)5:6<1182::aid-cncr2820050615>3.0.co;2-# | PMID 12998025